Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study

Abstract Objectives The objective of the study is to compare the efficacy and safety of alternative androgen therapy (AAT) with enzalutamide + androgen deprivation therapy (ADT) and flutamide + ADT in the treatment of Japanese men with metastatic or nonmetastatic castration‐resistant prostate cancer...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hiroji Uemura, Kazuki Kobayashi, Akira Yokomizo, Shiro Hinotsu, Shigeo Horie, Yoshiyuki Kakehi, Seiji Naito, Norio Nonomura, Osamu Ogawa, Mototsugu Oya, Kazuhiro Suzuki, Atsushi Saito, Satoshi Uno, Hideyuki Akaza
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-01-01
coleção:	BJUI Compass
Assuntos:	AFTERCAB alternative androgen therapy androgen deprivation therapy bicalutamide castration‐resistant prostate cancer combined androgen blockade
Acesso em linha:	https://doi.org/10.1002/bco2.103
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!